An Evaluation of the Safety and Clinical Utility of Handheld ECG Technology in Cardiology
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiac Arrhythmia
- Sponsor
- The Leeds Teaching Hospitals NHS Trust
- Enrollment
- 750
- Locations
- 1
- Primary Endpoint
- Difference between the 6 lead and the 12 lead Electrocardiogram
- Last Updated
- 5 years ago
Overview
Brief Summary
ECGs are routinely performed in cardiology. Recently handheld ECGs have shown promise in screening for heart rhythm disorders. These are quick to perform and do not require the preparation that is needed for 12 lead ECGs. We wanted to test whether a novel handheld ECG recorder, Kardia 6L, which has the potential to record a 6 lead ECG is able to screen for ECG abnormalities, thereby obviating the need for a full 12 lead ECG. This may allow for earlier diagnosis and treatment.
Detailed Description
The aim of analysis is to determine if the handheld 6 lead ECG can be used as a simple screener to identify patients who do not need a 12 lead ECG.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Anyone attending cardiology outpatients or the ward who has had a recent ECG (within 6 hours)
Exclusion Criteria
- •Patients who do not consent to the study
Outcomes
Primary Outcomes
Difference between the 6 lead and the 12 lead Electrocardiogram
Time Frame: 2 minutes
Sensitivity and specificity of handheld 6Lead compared to 12lead for the measurement of the stages of heart rhythms.